(Q37381313)

English

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

William J. Murphy

7

object named as

Murphy WJ

0 references

2

object named as

Longo DL

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Francis W. Ruscetti

6

object named as

Ruscetti FW

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Asai O

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tian ZG

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Hornung RL

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Taub DD

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

101

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1835-1842

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Biology of natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

6 September 2017

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

6 September 2017

Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

6 September 2017

Transforming growth factor-beta and the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

6 September 2017

Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

6 September 2017

Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

6 September 2017

Natural killer cells and bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

28 September 2017

The mechanism of IL-2-mediated protection against GVHD in mice. II. Protection occurs independently of NK/LAK cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

28 September 2017

Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

28 September 2017

Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

28 September 2017

In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

26 June 2018

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

26 June 2018

T-cell depletion of HLA-identical transplants in leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508768

26 June 2018

Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988-1990 survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-12 inhibits murine graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of murine graft-versus-host disease by inducing and eliminating ASGM1+ cells of donor origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9576746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI1268

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37381313&oldid=1703116819"